Tvardi Therapeutics, Inc.
TVRD$207M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSUGAR LAND12 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
This month
Market Overview
Stock performance and key metrics
TVRD News
Catalyst Timeline
3 upcoming, 0 past
Phase 2Next
TTI-101 Phase 2 Est. Readout
June 2026~ConfirmedTTI-101178
Primary completion for TTI-101 trial (NCT05440708) in Hepatocellular Carcinoma
Source2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TTI-101 | Phase 2 | Hepatocellular Carcinoma | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply